Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Select Medical Holdings Corp.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Select Medical Holdings Corp. (SEM) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM). Investors who purchased Select Medical prior to March 2, 2026, and continue to hold to the present are encouraged to obtain additional information and assist the investigation.
What Potential Securities Violations Is BG&G Investigating?
The investigation concerns whether Select Medical’s board of directors breached its fiduciary duties and failed to provide relevant information to its shareholders before the merger. On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share in cash. Following the closing of the proposed transaction, the company’s shares will no longer be publicly traded. The investigation focuses on whether Select Medical investors are being fairly compensated for their shares and whether the company’s leadership breached their fiduciary duties by approving the $16.50 per share transaction.
What Should Select Medical Holdings Corp. (SEM) Investors Do?
If you are aware of any facts relating to this investigation or purchased Select Medical securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
How Did Select Medical Holdings Corp. (SEM) Stock React?
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”